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Abstract
NK cells have been shown to either promote or protect from autoimmune diseases. Several studies have examined the role
of receptors preferentially expressed by NK cells in the spontaneous disease of NOD mice or the direct role of NK cells in
acute induced disease models of diabetes. Yet, the role of NK cells in spontaneous diabetes has not been directly addressed.
Here, we used the NOD.NK1.1 congenic mouse model to examine the role of NK cells in spontaneous diabetes. Significant
numbers of NK cells were only seen in the pancreas of mice with disease. Pancreatic NK cells displayed an activated surface
phenotype and proliferated more than NK cells from other tissues in the diseased mice. Nonetheless, depletion of NK cells
had no effect on dendritic cell maturation or T cell proliferation. In spontaneous disease, the deletion of NK cells had no
significant impact on disease onset. NK cells were also not required to promote disease induced by adoptively transferred
pathogenic CD4
+ T cells. Thus, NK cells are not required for spontaneous autoimmune diabetes in NOD mice.
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Introduction
The primary role of Natural Killer (NK) cells in the immune
system is to police the body for cells that have been infected by
pathogens or become tumorigenic [1]. Upon encountering these
targets, NK cells engage in an assortment of receptor - ligand
interactions and destroy cells that elicit sufficient activating signals,
countering inhibitory signals, to promote the stimulation of NK
cells. Many of the activating receptors expressed by NK cells
recognize self-ligands; thus, by nature, NK cells are autoreactive.
While once thought of as being important only for innate
immunity, recent studies have clearly demonstrated that NK cells
share characteristics with antigen-specific T cells [2,3,4]. The
ability of NK cells to rapidly elicit robust immune responses, in
combination with their ‘self-reactive’ nature, make them potential
players in autoimmune diseases.
Prior studies have demonstrated that NK cells can either protect
against or promote autoimmunity [5,6]. In some models of
experimental autoimmune encephalomyelitis (EAE), NK cells
reduce the magnitude of the T cell response by directly killing
activated T cells [7,8]. In this case, improving the function of NK
cells by blocking inhibitory signals delivered via NKG2A reduced
the severity of EAE. Additionally, NK cells at the site of
inflammation in the spinal cord could prevent T cell activity and
reduce EAE severity by the secretion of interferon gamma (IFNc)
[9]; however, if IL-18 was given during the induction of EAE, NK
cells promoted disease [10]. Likewise, NK cellscanhavediametrical
roles in rheumatoid arthritis; one study demonstrated that the
depletion of NK cells resulted in more severe arthritis with the
authors suggesting that NK cells inhibited Th17 cells by producing
IFNc [11], whereas another study showed that the depletion of NK
cells reduced the severity of bone erosion, demonstrating in vitro that
NK cells promoted osteoclast differentiation [12].
Similarly, in animal models of autoimmune diabetes, NK cells
can either be protective or harmful. For example, in NOD mice,
which develop diabetes spontaneously, the activation of NK cells
with poly I:C protects against diabetes through the secretion of
IFNc [13]. Yet, NK cells were also found to be disease-promoting
in NOD mice in models where disease was accelerated by
CTLA4-Ig treatment [14] or in BDC2.5 NOD mice, whose CD4
+
T cells express a transgene for an antigen-specific TCR to islets
[15]. Further evidence that NK cells might promote disease in
NOD mice are the examples that blocking the activating receptors
NKG2D [16] or NKp46 [17], which are highly expressed by NK
cells, dramatically reduced the onset of disease. Another study has
shown that NK cells in NOD mice infiltrate the pancreas and
appear to be activated, leading the authors to conclude that NK
cells promote diabetes [18]. Thus, recent evidence suggests that
NK cells promote the onset of diabetes in the NOD mouse in some
model systems; however, none of these studies directly examined
the requirement of NK cells in the onset of spontaneous disease.
Herein, using a congenic model of the NOD mouse that allows
direct targeting of NK cells, we examined the role of NK cells in
the spontaneous onset of autoimmune diabetes.
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Mice
Dr. Albert Bendelac (Univ. Chicago) kindly provided NOD.B6-
(D6Mit254-D6Mit289)/CarJ (referred to as NOD.NK1.1) mice.
NOD/MrkTac and NOD/MrkBomTac-Prkdc
scid (referred to as
NOD.Scid) mice were purchased from Taconic. Dr. Mark
Anderson (UCSF) provided B6.H2
g7 mice. Dr. Jeffrey Bluestone
(UCSF) generated the NOD.Cg-Prkdc
scid Il2rg
tm1Sug/JicTac mice
(referred to as NSG). Rag2
2/2 NOD.NK1.1 mice were generated
by breeding NOD.NK1.1 mice by NOD.Rag2
2/2 mice. All mice
were maintained in the specific pathogen-free animal facility of the
University of California, San Francisco. The Institutional Animal
Care and Use Committee of the University of California, San
Francisco approved animal protocols.
Pancreatic digestions
Lethally anesthetized mice were perfused with 30 ml of a 2%
heparin PBS solution. The pancreas was then placed in 2 ml of
media containing 2 mg/ml of collagenase type V (Sigma) and
10 mg/ml DNAse I (Sigma) for 30 min at 37uC. Homogenates
were then resuspended in a 40% Percoll (in PBS) gradient layered
over a 60% Percoll (in PBS) layer and were centrifuged for 20 min
at 3006g. The buffy layer was then removed and washed to
prepare the cells for flow cytometry or in vitro functional assays.
Islet isolation
Pancreata were perfused with collagenase type V (Sigma-
Aldrich) and digested for 12 min in a 37uC water bath. Islets were
purified by using Histopaque and handpicked. Purified islets were
dissociated by incubation with an enzyme-free dissociation buffer
(Invitrogen) and mixing by pipette.
NK cell stimulation
NK cells from spleen were enriched by incubating splenocytes at
4uC for 15 minutes with anti–glycophorin A (Ter119), anti-CD4
(GK1.5), anti-CD5 (53-7.3), anti-CD8 (YTS 169.4), and anti-CD19
(1D3), washed, and then resuspended with metallic beads coated
withgoat anti–rat IgG(QIAGEN) for30 minutesat 4uC. Antibody-
labeled cells were removed by magnetic separation. Enriched NK
cells were incubated on plates coated with 10 mg/mL anti-NKG2D
(CX5), anti-Ly49D (4E5) (BD Biosciences), or an isotype-matched
control mAb (blockade with 2.4G2 had no effect on the stimulation,
excluding activation via CD16 on NK cells) or with 20 ng/mL IL-
12 and 5 ng/mL IL-18 (R&D Systems) in the presence of brefeldin
A. Cells were surface stained with mAbs to NKp46 (R&D Systems),
NK1.1, T cell receptor b (TCRb) (H57-597) (BioLegend), and
CD107a (1D4B) (BD Biosciences), and then permeabilized and
stained intracellularly with anti-IFNc mAb (XMG1.2) by using an
Intracellular Staining Kit (BD Biosciences).
Multicolor immunofluorescent labeling and confocal
microscopy
Seven-micron sections were prepared from pancreata frozen in
OCT
TM medium and fixed in ice-cold acetone for 10 min.
Endogenous peroxidase activity was quenched in 3% H2O2 and
0.1% sodium azide for 1 h. After treating sections with blocking
reagent (Perkin Elmer) supplemented with 3% donkey serum plus
1% normal mouse serum, sections were incubated overnight with
a goat anti-mouse NKp46 antibody (R&D Systems), followed by
peroxidase-conjugated donkey anti-goat IgG (Jackson ImmunoR-
esearch) for one hour and then TMR tyramide (Perkin Elmer) for
7 min. Tissue sections were then incubated overnight with guinea
pig anti- mouse insulin (Invitrogen), followed by AlexaFluor 647-
conjugated goat anti-guinea pig IgG (Invitrogen). Fluorescent
staining patterns were detected and acquired by serial imaging on
a Zeiss LSM 5 Pascal confocal microscope.
Adoptive transfer
CD4
+ T cells were isolated by using an AutoMacs (Miltenyi
Biotec), and 5610
6 purified CD4
+ T cells were transferred into
immunodeficient hosts. To remove any possible contamination of
CD8
+ T cells, recipients received 200 mg of a depleting anti-CD8
mAb (53.6.7) weekly for the duration of the experiment. All
recipients were checked for lymphocyte depletion at the end of the
treatment by flow cytometry. An initial 500 mg of anti-NK1.1
(PK136) was given on day 21 prior to cell transfer and 100 mg
weekly for the duration of the experiment. Likewise, controls were
given mouse IgG2a (BioXCell).
Disease Onset
Mice were monitored for onset of disease, considered as the first
reading of $16 mM blood glucose, followed by two more
consecutive readings of $16 mM blood glucose. Treated mice
received either 200 mg anti-NK1.1 or a control mouse IgG2a
weekly from weeks 3 to 10 weeks of age. Experimental groups were
matched with littermate controls, i.e., one anti-NK1.1-treated
recipient was matched with a control mouse IgG2a-treated
littermate. Ten different litters were observed over a 1-year period
for spontaneous onset of diabetes.
Results
NK cells are present in the NOD pancreas
NK cells have been found previously in the infiltrates of tumors
and autoimmune inflammatory sites [5,19]. NK cells were found
in the pancreas of NOD mice, as demonstrated by the detection of
NKp46
+ TCRb
2 infiltrates by flow cytometry (Figure 1a). The
percentage of NK cells consistently fell in between the frequency of
NK cells present in liver and the spleen when all tissues were
treated in a similar manner. Also, a unique population of NKp46
+
TCRb
+ T cells was distinctly evident in the liver and pancreas
(Figure 1a). The NK cells were found both in the islets and the
surrounding acinar tissues (Figure 1b), in accordance with other
recent findings [18]. In the non-autoimmune B6.g7 strain with the
same MHC as NOD mice, NK cells were rarely found in the
pancreas (Fig. 1c). NK1.1-congenic and wild-type NOD mice had
equivalent frequencies of NK cells in the pancreas (Figure 1d). In
some animals, NK cells were found in small numbers even in
Rag2
2/2 NOD mice, but were extremely rare in the pancreas of
Rag-deficient B6.g7 mice as detected by flow cytometry (Figure 1e),
but were below our levels of detection by immunohistochemistry
(data not shown). The absolute number of NK cells in the pancreas
of NOD and NOD.NK1.1 mice were similar, and significantly
more than in Rag2
2/2 NOD, B6.g7, and Rag1
2/2 B6.g7 mice
(Figure 1f). Thus, disease-state and non-MHC genes play a role in
the trafficking of NK cells into the pancreas.
Pancreatic NK cell are proliferating and have an activated
surface phenotype
We compared the phenotypes of NK cells isolated from the
pancreas of 8 week-old NOD mice to NK cells in the spleen and
liver. A higher proportion of NK cells isolated from the pancreas
incorporated BrdU in comparison to NK cells found in the spleen
and liver and to T cells in the same tissues (Figure 2a). While a
higher percentage of NK cells incorporated BrdU compared to
other lymphocyte populations throughout all tissues, a higher
NK Cells in Spontaneous Autoimmune Diabetes
PLoS ONE | www.plosone.org 2 April 2012 | Volume 7 | Issue 4 | e36011frequency of NK cells in the pancreas and pancreatic lymph nodes
incorporated BrdU relative to other lymphocytes when compared
to NK cells from other tissues (Figure 2b). This was specific to the
disease state as intra-pancreatic NK cells from Rag2
2/2NOD mice
did not display this increased proliferation (Figure 2c and 2d).
These data suggest that the NK cells from the diseased pancreas
proliferate at higher rates than NK cells found in other tissues.
The maturation states determined by CD11b and CD27
staining [20] differed on pancreatic NK cells and splenic NK
cells (Figure 3a) from NOD mice as determined by comparing the
relative percentages of NK cells expressing these markers.
However, the cell surface density of both of these markers (as
determined by mean florescence intensity) was lower on pancreatic
NK cells relative to splenic NK cells (Figure 3b). Pancreatic NK
cells from NOD mice had slightly higher levels of CD69 and a
higher percentage of NK cells expressing CD11c, and lower
expression levels of CD49b, CD43, and NKp46 than on splenic
NK cells (Figure 3b). This difference in phenotype was not general
to tissue-residing NK cells as NK cells isolated from liver were
more similar to splenic NK cells, with exception that NK cells in
liver displayed lower amounts of CD27 and a higher frequency of
KLRG1
+ NK cells than splenic NK cells (Fig. 3b). These data
indicate that pancreatic NK cells are activated and proliferating
more than NK cells in other tissues of NOD mice.
Pancreatic and liver NK cells have impaired ex vivo
responses
Primed and activated NK cells have more robust responses
compared to resting NK cells [2,4]. Using plate-bound antibodies
to the activating NK cell receptor Ly49D and CD107a as a
marker of granule release, we examined the cytolytic potential of
NK cells. Although the frequency of NK cells expressing Ly49D
was equivalent in spleen, liver, and pancreas, pancreatic NK cells
had a decreased ability to degranulate relative to those isolated
from the spleen. NK cells isolated from the liver were similar to
pancreatic NK cells (Figure 4a and 4b). To determine if this
hyporesponsiveness was restricted to Ly49D receptor-induced
activation, we stimulated NK cells with a combination of IL-12
Figure 1. NK cells reside in the pancreas. A) Flow cytometric analysis of leukocytes isolated from enzyme-digested tissues of NOD mice. Plots are
of CD45
+ cells and numbers are percentages of CD45
+ cells. Example of one of six similar experiments. B) Using immunohistochemistry, NK cells (red)
were found in the surrounding peri-islet infiltrates (left panel 406) and in infiltrated islets (right panel 206). Insulin was stained green to define islets.
Example of sections of pancreas from three different NOD mice, evaluating a minimum of 10 slides per mouse. C) NK cells were more numerous in
NOD pancreas compared to B6.g7 pancreas– dots were enlarged to allow visualization of NK cells due to low number of events obtained from B6.g7
mice. D) NOD.NK1.1 pancreata contain similar frequencies of NK cells as NOD mice. E) Rag2
2/2 NOD mice have low numbers of NK cells in their
pancreas, whereas Rag1
2/2 B6.g7 mice have very few, almost undetectable numbers of NK cells in the pancreas. F) Absolute numbers of NK cells
recovered from the pancreas of individual mice from noted strains. Example from one of six similar experiments, each with a minimum of three mice
per strain is shown.
doi:10.1371/journal.pone.0036011.g001
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liver showed a lower cytokine response relative to NK cells from
peripheral blood and secondary lymphoid tissues (Figure 4c). NK
cells were isolated from all tissues using similar techniques,
suggesting that NK cells isolated from organ tissues compared to
secondary lymphoid tissues are refractory in their ex vivo responses.
In vivo responses by pancreatic NK cells are intact
Given the possibility that isolation from organ tissues might
compromise NK cell function, we analyzed NK cell responses to the
TLR3 agonist, polyinosinic-polycytidylic acid (poly I:C), in vivo.T h e
NK cell response induced by poly I:C is indirect via antigen-
presenting cells, and thus requires cell-cell and receptor-mediated
interactions [21]. Increased expression of CD69 was similar in NK
cells from the spleen, liver, and pancreas (Figure 5a). Likewise,
immediate ex vivo intracellular staining of IFNc (no in vitro stimulation)
demonstrated no difference in the NK cell response from these three
tissues (Figure 5b). Thus, the response ofpancreatic and liver NK cells
in vivo to poly I:C is similar to those found in the spleen.
Pancreatic NK cells have no influence on intra-islet DC
maturation
In addition to cytokine production and killing, NK cells can
have effects on the immune response through cognate interactions
with dendritic cells (DC) [22]. We examined the influence of NK
cells on intra-islet DC maturation as determined by expression of
CD40, CD11b, CD86, and CD80 [23]. We used the disease-free
NSG model, NOD.Cg-Prkdc
scid Il2rg
tm1Sug/JicTac mice that lack
NK cells (Figure 6a), to define the ‘resting’ intra-islet DC
phenotype. CD45
+CD11c
+I-A
g7+ cells were found within isolated
islets from all strains of mice with or without the presence of NK
cells (Figure 6b). The small number of NK cells found in the islets
from Rag2
2/2 NOD mice did not promote any further DC
maturation when compared to the NSG DCs (Figure 6c-top row).
Moreover, DCs from anti-NK1.1-treated NOD.NK1.1 mice
versus control mouse IgG2a-treated NOD.NK1.1 mice demon-
strated no difference in DC maturation (Fig. 6c-bottom row).
Thus, the presence of NK cells in the pancreas does not influence
the maturation status of DCs.
NK cells are not required for disease
Islet inflammation has been detected as early as four weeks of
age in NOD mice [24]. Thus, NK cell depletion in NK1.1-
congenic NOD mice was started when the pups reached 14 days-
old to eliminate NK cells before any initiation of disease; NK cell
depletion was efficient even after 8 weeks of therapy (Figure 6A).
Full recovery of peripheral NK cells levels was not seen until a
minimum of 14 days later, at 12 weeks of age. Disease onset was
Figure 2. NK cells within the pancreas proliferate at a higher rate than NK cells in the periphery. Plots shown are gated on NKp46
+
TCRb
2 lymphocytes day 3 after daily injections of 200 mg BrdU. A) NK cells from NOD mice incorporate BrdU at a higher rate than T cells in the same
tissue. B) A higher frequency of NK cells in the pancreas are proliferating compared to NK cells in the spleen of NOD mice, relative to the same
comparison of T cells in the pancreas and spleen. Bar graph of three NOD mice in one experiment C) The higher proliferation of pancreatic NK cells in
NOD mice is dependent on the presence of adaptive immunity as pancreatic NK cells in Rag2
2/2 NOD mice did not incorporate more BrdU than
splenic or liver NK cells. D) Bar graph of three Rag2
2/2 NOD mice. In some cases mice were pooled to obtain sufficient numbers of NK cells. One
representative experiment of three independent experiments is shown.
doi:10.1371/journal.pone.0036011.g002
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(Figure 7a). Adoptive transfer of purified CD4
+ T cell from recent-
onset diabetic NOD mice into Rag2
2/2 NOD.NK1.1 recipients,
also treated with anti-CD8 to eliminate any contaminating CD8
+
T cells, demonstrated similar results. In this model, the elimination
of endogenous recipient NK cells had little influence on disease
(Figure 7a). The loss of NK cells impacted the disease rate by
slightly delaying the onset of transferred disease, but not
significantly. The penetrance of CD4
+ T cell-induced disease
was similar with or without NK cells, with 75% of recipients
becoming diabetic by 150 days. The results were similar to the
spontaneous wildtype model in that the onset rate was slightly
delayed in the absence of NK cells (and NKT cells, which are also
depleted by anti-NK1.1 treatment), but the final disease
penetrance was similar. Thus, NK cells are not required for
disease progression and diabetes onset in NOD.NK1.1 mice.
Further detailed analysis of T cells from 10 week-old mice also
did not display any overt differences between NK cell-depleted
mice and NK cell-replete mice. BrdU analysis demonstrated no
differences in CD4
+ and CD8
+ T cell proliferation in the pancreas,
draining pancreatic lymph node, and spleen of mice depleted of
NK cells compared to controls (7b). Cytokine responses, detected
by intracellular staining of ex vivo re-stimulated T cells, demon-
strated no difference in cytokine production by CD4
+ or CD8
+ T
cells in the pancreatic nodes (Figure 7c). Similar results were noted
when examining pancreatic infiltrating T cells (Figure 7c). Thus,
there was no significant difference in the T cell profiles of anti-
NK1.1-treated NOD.NK1.1 mice compared to isotype control-
treated mice.
Discussion
In this study, we examined the contribution of NK cells to
spontaneous diabetes in NOD and NOD.NK1.1 mice. NK cells
from NOD mice do not express a marker that can be targeted by
currently available antibodies for depletion and therefore this
study required the use of the NK1.1-congenic NOD strain to allow
for in vivo targeted depletion of NK cells. Using NKp46 as a
marker for NK cells in NOD mice, we found that NK cells were
found in comparable numbers in the diseased pancreata of NOD
mice and NOD.NK1.1 mice.
The presence of significant numbers of NK cells in the pancreas
is specific to the NOD mouse and disease state. Few (or in some
experiments no) NK cells were found in the pancreas of B6.g7
Figure 3. Pancreatic NK cells have an activated phenotype. A)
NK cells pooled from five 8-week-old NOD mice were assayed for
maturational status using CD11b and CD27. Both the pancreas and liver
had more CD11b
loCD27
lo NK cells than in the spleen. B) Histograms of
CD11b and CD27 (gated on CD3-, NKp46
+ cells) demonstrate a lower
mean fluorescence intensity of these markers on pancreatic NK cells
relative to splenic NK cells. CD11c, CD69, and KLRG1 were increased on
pancreatic NK cells. Lower expression of CD49b, CD43, and NKp46 on
pancreatic NK cells was also indicative of activation. Example from one
of five similar experiments is shown.
doi:10.1371/journal.pone.0036011.g003
Figure 4. Ex vivo cytolytic potential and cytokine secretion are
lower in pancreatic and liver NK cells. A) NK cells pooled from five
8-week-old NOD mice were stimulated for four hours with plate-bound
anti-Ly49D in the presence of an antibody to CD107a to mark cytolytic
granule release. B) Summary of results from 3 experiments. * p,0.05
versus all other groups (unpaired T test). C) NK cells pooled from 8-
week-old NOD mice were stimulated with IL-12+IL-18 in the presence
brefeldin A for four hours and then stained for intracellular IFNc. Results
are pooled from 4 independent experiments. * The frequency of NK
cells producing IFNc in blood was significantly higher than NK cells in
pancreatic (Pan) or inguinal (Ing) lymph nodes (p,0.005) and in the
liver and pancreas (p,0.0001), **% of NK cells expressing IFNc in both
nodes was higher than in the pancreas (p,0.001), # % of NK cells
expressing IFNc in the spleen was significantly higher than in pancreas
(p=0.04). NS, there was not a significant difference between the
percentage of NK cells expressing IFNc in the liver and pancreas
according to an unpaired T test.
doi:10.1371/journal.pone.0036011.g004
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consistently lower than in Rag2
2/2 NOD mice, which had much
fewer numbers of NK cells in the pancreas compared to diseased
NOD mice. These results differ from another study in which they
found significant numbers of NK cells in the pancreas of B6.g7
mice [18]. The method of cell isolation from the pancreas might
be responsible for this difference as we perfused our mice to
remove any circulating NK cells from the blood prior to tissue
harvest; it is unknown if the previous study followed a similar
protocol. We also did not detect NK cells in the pancreas of
Rag2
2/2 NOD mice and B6.g7 by immunohistochemistry.
Collectively, data from experiments evaluating Rag2
2/2 and
wild-type NOD mice suggest that the NOD pancreas harbors a
unique environment for NK cells, but the infiltration of significant
numbers of NK cells requires the presence of adaptive immunity.
Pancreatic NK cells in NOD and NOD.NK1.1 mice have an
activated surface phenotype, but results from our ex vivo
stimulation assays suggest that pancreatic NK cells are somewhat
hyporesponsive as measured by their capacity to degranulate or
produce IFNc, consistent with prior finding [18]. Yet, because the
pancreatic NK cells were similar in their responsiveness to liver
NK cells in NOD mice, this hyporesponsiveness is not specific to
pancreatic NK cells, but might be due to the methods used to
isolate NK cells from solid organs or the unique microenvironment
of tissues. Consistent with this interpretation, we have also noted a
lower responsiveness of liver NK cells compared to splenic NK
cells in C57BL/6 mice (our unpublished observations). In contrast,
the in vivo response to poly I:C by liver and pancreatic NK cells
was equal to that of splenic NK cells, suggesting that indeed these
pancreatic NK cells are capable of responding quickly, similar to
NK cells from the spleen.
Dendritic cell maturation is important to T cell activation and
autoimmune disease progression [23]. DCs from Rag2
2/2 NOD
mice displayed the same maturational phenotype as DCs from the
NK cell-deficient NOG strain mice. Thus, at steady-state NK cells
did not promote DC maturation in the absence of an adaptive
immune system in NOD mice. Moreover, the activation status of
DCs in NOD mice was not affected by the depletion of NK cells.
Therefore, NK cells are not required for pancreatic DC
maturation or activation in NOD mice. Thus, when using DCs
as sentinels of disease status [23], the absence of NK cells doesn’t
appear to inhibit the progression of inflammation in the islets.
The early deletion of NK cells in NOD.NK1.1 mice by depleting
antibody treatment was used to determine the role of NK cells in
disease initiation or their contribution as effectors. The adoptive
transfer of only CD4
+ T cells from diabetic NOD mice into Rag-
deficient NOD hosts bypasses the need to prime and activate
pathogenic CD4
+ T cells and excludes participation of CD8
+ Tc e l l s
in induction of disease. Additionally, the time period to disease onset
in this adoptively transferred CD4
+ T cell model is similar to that of
Figure 5. In vivo activation of pancreatic NK cells is intact. A)
CD69 expression on NK cells from NOD mice injected with 200 mg poly
I:C (solid line) versus control NOD mice injected with PBS (filled
histogram). Colored numbers matching the respective histograms
indicate median fluorescence intensity. One representative experiment
of three independent experiments is shown. B) NK cells harvested from
the mice in (A) were immediately stained ex vivo (without any in vitro
stimulation) for intracellular IFNc. Results were combined from 3
independent experiments.
doi:10.1371/journal.pone.0036011.g005
Figure 6. NK cells do not influence intra-islet DC maturation in
NOD mice. A) NK cells were not detected in islets from NSG mice (first
panel on left) or NOD.NK1.1 mice treated with anti-NK1.1 (far right
panel), but were found in islets from Rag2
2/2 NOD mice and
NOD.NK1.1 mice treated for 8 weeks with isotype-matched control
IgG. Plots are of CD45
+ cells isolated from islets of 10 week-old mice and
numbers represent percentages of total CD45
+ cells. B) DCs were
detected in islets of NSG and Rag2
2/2 NOD mice, and in the islets of
NOD.NK1.1 mice treated with isotype-matched control IgG or anti-
NK1.1 (a-NK1.1). Plots are of CD45
+ cells isolated from islets of 10 week-
old mice and numbers represent percentages of total CD45
+ cells. C) NK
cells in Rag2
2/2 NOD mice do not promote DC maturation relative to
the NK cell-deficient NSG mice (top row) as there was no difference in
maturation marker expression on DC in Rag2
2/2 NOD and NSG mice.
NOD.NK1.1 mice treated with anti-NK1.1 or an isotype-matched control
IgG have DCs of similar maturation status (bottom row). One
representative experiment of three independent experiments is shown.
doi:10.1371/journal.pone.0036011.g006
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Rag-deficient NOD hosts, we used this sensitive in vivo assay to
demonstrate that NK cells have no role in the effector phase of
disease in this model. Thus, NK cells do not mediate islet
destruction. Likewise, when NK cells were depleted in the model
of spontaneous disease in intact NOD mice, no differences in BrdU
incorporation by CD4
+ T cells or CD8
+ T cells were demonstrated.
Thesedataalsosupportthe finding that depletionof NKcellshad no
significant impact on the onset of spontaneous disease inNOD mice.
Targeting of either NKG2D or NKp46 in NOD mice prevents
the onset of diabetes, but our results here suggest that these
outcomes are not due to the targeting of NK cells. Indeed, NK
cells can kill islets in vitro, and islets express ligands for the
activating receptors NKG2D and NKp46 [16,17]. NKG2D is
expressed by activated T cells and was suggested as the target for
anti-NKG2D therapy [16]. The study that targeted the NKp46
pathway by treating mice with a NKp46-Fc fusion protein did not
directly implicate NK cells by addressing the efficacy of this
therapy in the absence of NK cells in NOD mice, an important
consideration given that NKp46 is expressed on some cd T cells,
some non-NK innate lymphoid cells, and a subset of ab TCR-
bearing T cells identified in our study. It is also possible that a
receptor other than NKp46 recognizes this NKp46 ligand and that
NKp46-Fc therapy prevents that interaction. With respect to this
study, the NKp46-Fc therapy does not target the same cells as
anti-NK1.1 therapy. Anti-NK1.1 depletes NK cells and NKT
cells. NKT cells have been shown to be protective in NOD mice if
their activity is induced [25]. NK1.1 depletion does not target
NKp46
+ NK1.1
2 cells in the intestinal lumen that produce IL-22,
which is important for gut homeostasis [26]. As noted above, IFNc
production by activated NK cells is protective from diabetes. The
loss of NKp46 does appear to affect homeostasis of NK cells in the
gut and their ability to produce IFNc in response to IL-12 and IL-
18. Gut homeostasis is directly linked to diabetes in NOD mice as
MyD88-deficient mice only develop diabetes in germ-free
conditions [27]. Of note, the important NK cell activation factor
IL-18 is not required for diabetes as MyD88 signaling is necessary
to process functional IL-18.
A possible explanation for low NK cell function in NOD mice is
that these mice have a poorly expressed Il15 allele [28]. The
Figure 7. NK cells are not required for the progression to diabetes. A) The left panel shows the rate of spontaneous diabetes in NOD.NK1.1
littermates that received either anti-NK1.1 or an isotype-matched control IgG from 3 through 10 weeks of age (10 litters). In the middle panel, purified
CD4
+ T cells from diabetic NOD mice were transferred into Rag2
2/2 NOD.NK1.1 mice and treated with anti-NK1.1 or an isotype-matched control IgG.
Both groups in the adoptive transfer experiments also received anti-CD8 to ensure exclusively CD4
+ T cell-mediated disease. The far right panel
shows the incidence of disease in unmanipulated NOD mice and NOD.NK1.1 mice in our colony. P values were calculated using the Mann-Whitney U
test. B) Five hundred micrograms of BrdU was in injected intravenously and mice were sacrificed one hour later. Flow cytometric plots of cells isolated
from the pancreas from one representative experiment are shown. Graphs are cumulative of 3 independent experiments involving littermates. C)
NOD.NK1.1 mice were sacrificed after 10 weeks after receiving noted treatment regimens. Isolated leukocytes from the pancreatic lymph node or
pancreas with stimulation with PMA and ionomycin for 3 hours in the presence of GolgiStop and assayed for intracellular IFNc or IL-17 production by
CD4
+ T cells or CD8
+ T cells, as indicated. Graphs are cumulative of 3 independent experiments involving littermates. No significant difference
between groups was demonstrated in any parameter assayed.
doi:10.1371/journal.pone.0036011.g007
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15R complexes dramatically accelerated disease onset in BDC2.5
NOD mice, suggesting that fully functional, activated NK cells
may contribute to diabetes. Indeed, in our studies presented here
the deletion of NK cells had modest, but not statistically
significant, effects on the rate of spontaneous disease in NOD
mice. However, significant delays in disease in NOD mice were
demonstrated with transient depletion of either CD4
+ or CD8
+ T
cells [29]. Thus, the recruitment and activation of NK cells in the
pancreas of diseased mice appears to be a consequence of the
disease pathogenesis and not a required driver of disease. In some
instances, these activated pancreatic NK cells might contribute
enough to the inflammatory milieu to promote disease progres-
sion, which might explain why primed CD4
+ T cells take a little
longer to promote disease in the absence of NK cells and why
there is a slight delay in the spontaneous development of diabetes
in NOD mice. Our results do not support a direct role of NK cells
in islet destruction or a significant role for NK cells in the priming
of pathogenic T cells, but future studies might explore the
potential role of NK cells in the recruitment of T cells into the
pancreas (e.g. by production of chemokines) since the absence of
NK cells during adoptive transfer demonstrated a clear delay in
onset. Finally, our finding, combined with other recent studies,
suggest that NK cells can play a role in diabetes in mice on the
NOD background when manipulated, but that spontaneous
disease ultimately does not require NK cells.
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